Ignite Creation Date:
2024-05-06 @ 12:15 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01528345
Status:
TERMINATED
Last Update Posted:
2016-07-11
First Post:
2012-01-31
Brief Title:
Trial Evaluating Dovitinib Combined With Fulvestrant in Postmenopausal Patients With HER2- and HR Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis